Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials
2022
370 citations
Journal Article
Field-Weighted Citation Impact:
65.42
Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials | Researchclopedia
·
Icahn School of Medicine at Mount Sinai
Brian G. Feagan
·
Western University
Tadakazu Hisamatsu
·
Kyorin University
Allen Lim
·
University of Alberta
James O. Lindsay
·
Queen Mary University of London
Edward V. Loftus
·
Mayo Clinic
Julián Panés
·
Centro de Investigación Biomédica en Red
Laurent Peyrin‐Biroulet
·
Inserm
Zhihua Ran
·
Shanghai Jiao Tong University
David T. Rubin
·
University of Chicago
William J. Sandborn
·
University of California San Diego
Stefan Schreiber
·
Christian-Albrechts-Universität zu Kiel
Ezequiel Neimark
·
AbbVie (United States)
Alexandra Song
·
AbbVie (United States)
Kristina Kligys
·
AbbVie (United States)
Yinuo Pang
·
AbbVie (United States)
Valerie Pivorunas
·
AbbVie (United States)
Sofie Berg
·
AbbVie (United States)
W. Rachel Duan
·
AbbVie (United States)
Bidan Huang
·
AbbVie (United States)
Jasmina Kalabic
·
AbbVie (Germany)
Xiaomei Liao
·
AbbVie (United States)
Anne Robinson
·
AbbVie (United States)
Kori Wallace
·
AbbVie (United States)
Marc Ferrante
·
KU Leuven